TRPC6 and early-onset autosomal dominant Alzheimer disease: Also, pharmacological activation of TRPC6 inhibited the elevation of Aβ and phospho-tau in neurons of patients (Tao et al., 2020), indicating a possible protective role of TRPC6 in Alzheimer’s-disease.